Response to teriparatide in Chinese patients with established osteoporosis: osteocalcin and lumbar spine bone-mineral density changes from teriparatide Phase III study
Chunyan Lu,1 Yun Chen,2 Bin Zhang,2 Yu Chen,2 Fan Bai,2 Decai Chen1 1Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu, China; 2Lilly Suzhou Pharmaceutical Co. Ltd, Shanghai, China Abstract: Teriparatide is the first anabolic agent for osteoporosis, and t...
Saved in:
Main Authors: | , , , , |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2017
|
Subjects: | |
Online Access: | https://doaj.org/article/b9ac0f2e0dc640189aaaabb618b28cfd |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!